Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPRG.L Regulatory News (PRG)

  • There is currently no data for PRG

Rule 8.3- Premier Research Gr

20 May 2008 14:13

RNS Number : 8885U
Kaupthing Bank hf
20 May 2008
Β 

ο»Ώ

Β  FORM 8.3

DEALINGS BY PERSONS WITH INTERESTS IN SECURITIES REPRESENTING 1% OR MOREΒ 

(Rule 8.3 ofΒ theΒ TakeoverΒ Code)

1. KEY INFORMATION

Name of person dealingΒ Β (Note 1)

Kaupthing Bank hf

Company dealt in

Premier Research Group

Class of relevant security to which the dealings being disclosed relateΒ (Note 2)

Ordinary Shares

Date of dealing

19Β MayΒ 2008

2. INTERESTS, SHORT POSITIONS AND RIGHTS TO SUBSCRIBE

(a) InterestsΒ and short positionsΒ (following dealing) in the class of relevant security dealt inΒ (Note 3)

Long

Short

Number (%)

Number (%)

(1) Relevant securitiesΒ 

1,994 (0.003%)

(2) DerivativesΒ (other than options)

1,853,516 (3.08%)

1,853,516 (3.08%)

(3)Β OptionsΒ and agreements to purchase/sell

Total

1,853,516 (3.08%)

1,855,510 (3.09%)

(b) InterestsΒ and short positionsΒ in relevant securities of the company, other than theΒ classΒ dealt inΒ (Note 3)

Class of relevant security:

Long

Short

Number (%)

Number (%)

(1) Relevant securitiesΒ 

(2) DerivativesΒ (other than options)

(3)Β OptionsΒ and agreements to purchase/sell

Total

(c) Rights to subscribeΒ (Note 3)

Class of relevant security:

Details

3. DEALINGSΒ (Note 4)

(a) Purchases and sales

Purchase/sale

Number of securities

Price per unitΒ (Note 5)

Sell

1,994

99.42p

Β (b) Derivatives transactions (other than options)

Product name,Β 

e.g. CFD

Long/shortΒ (NoteΒ 6)

Number of securitiesΒ (Note 7)

Price per unitΒ (Note 5)

(c) Options transactions in respect of existing securities

(i) Writing, selling, purchasing or varying

Product name,

e.g.Β callΒ option

Writing, selling, purchasing, varying etc.

Number of securitiesΒ to which the option relatesΒ (Note 7)

Exercise

priceΒ 

Type,Β e.g. American, European etc.

ExpiryΒ 

date

Option money

paid/receivedΒ per unitΒ (Note 5)Β 

(ii) Exercising

Product name,Β e.g.Β call option

Number of securitiesΒ 

Exercise priceΒ per unitΒ (Note 5)

(d) Other dealings (including new securities)Β (Note 4)

Nature of transactionΒ (Note 8)

Details

PriceΒ per unitΒ (if applicable)Β (Note 5)

4. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relatingΒ to the voting rights of any relevant securities under any option referred to on this form orΒ relating to the voting rights orΒ future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

No voting rights on CFD holdings

Is a Supplemental Form 8 attached?Β (Note 9) NO

Date of disclosure

20Β MayΒ 2008

Contact name

Richard Easton

Telephone number

0203 205 6620

If a connected EFM, name of offeree/offeror with which connected

If a connected EFM,Β state natureΒ of connectionΒ (NoteΒ 10)

Notes

The Notes on Form 8.3 can be viewed on the Takeover Panel's website atΒ www.thetakeoverpanel.org.uk

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
RETEADSEAFAPEFE
Date   Source Headline
25th Mar 20138:00 amRNSDirectorate Change
6th Mar 20137:00 amRNSLemphane, Operational update
31st Jan 20137:40 amRNSLemphane operational update
14th Jan 20137:00 amRNSScoping study and drilling contracts
8th Jan 20137:00 amRNSMemorandum of Understanding
19th Dec 20128:46 amRNSDirectorate Change
3rd Dec 201212:36 pmRNSOperational Update
25th Sep 20127:00 amRNSDirectorate Change
19th Sep 20127:00 amRNSHalf Yearly Report
4th Sep 20127:00 amRNSOperational Update - Motete Dyke
28th Aug 20127:00 amRNSMotete update
24th Jul 20127:00 amRNSFurther Bulk Sample Results, Motete Dyke project
9th Jul 201212:11 pmRNSResult of AGM
4th Jul 20128:47 amRNSPreliminary Bulk Sample Results
8th Jun 201210:49 amRNSHolding(s) in Company
7th Jun 20121:39 pmRNSDirector/PDMR Shareholding
6th Jun 201211:08 amRNSLicence Extension Awarded
1st Jun 20127:00 amRNSAnnual Financial Report
31st May 201210:28 amRNSTotal Voting Rights
26th Apr 20127:00 amRNSAcquisition of remaining interest in IDC
13th Apr 20127:00 amRNSOperational Update at Motete Dyke
12th Apr 20122:38 pmRNSOperational Update
11th Apr 20127:00 amRNSFurther bulk sampling results from Lemphane
29th Mar 20127:00 amRNSCompletion of Micro-Diamond Recovery at Motete
26th Mar 20127:00 amRNSLaunch of website
19th Mar 201210:54 amRNSHolding(s) in Company
15th Mar 201210:55 amRNSHolding(s) in Company
1st Mar 20127:00 amRNSTotal Voting Rights
24th Feb 20127:00 amRNSNew Exploration Targets Identified in Lesotho
16th Feb 20127:00 amRNSFirst Large Diamonds Recovered from Lemphane
7th Feb 20127:00 amRNSFurther positive micro-diamond results from Motete
26th Jan 201212:25 pmRNSFundraising and Issue of Equity
18th Jan 20128:45 amRNSDirectorate Change
16th Jan 20127:00 amRNSDiamond grade and volumetric estimate at Motete
9th Jan 20127:00 amRNSFurther results from large micro-diamond sample
4th Jan 20127:00 amRNSPositive results from first micro-diamond sample
7th Dec 20117:00 amRNSAppointment of Nominated Adviser
1st Dec 20117:00 amRNSAward of License
7th Nov 20117:00 amRNSCommencement of bulk sampling at Lemphane, Lesotho
27th Sep 20117:00 amRNSInterim Results
31st Aug 20112:44 pmRNSUpdate on Operations and Exploration
29th Jul 20113:44 pmRNSTotal Voting Rights
26th Jul 20111:47 pmRNSDiamond and Gold Sale
26th Jul 201110:46 amRNSAward of Licence
14th Jul 20117:00 amRNSMineral Chemistry Results
21st Jun 201111:57 amRNSStatement re Further Directorate Change
21st Jun 20117:00 amRNSDirectorate Change
18th May 20117:00 amRNSCompletion of acquisiton of IDC
12th May 201111:29 amRNSResult of AGM
11th May 201111:48 amRNSDirector Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.